Gregory J. Dore
Impact in
- Hepatology top 0.01%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 0.02%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- HIV, Drug Use, Sexual Risk
Papers in
- Hepatology 358
- Hepatitis C virus research 356
- Epidemiology 240
- Hepatitis B Virus Studies 158
- Liver Disease Diagnosis and Treatment 112
- HIV, Drug Use, Sexual Risk 58
- Co-authors
- Jason Grebely (227 shared papers)John Kaldor (70 shared papers)Behzad Hajarizadeh (101 shared papers)Matthew Law (58 shared papers)Gail Matthews (124 shared papers)Hla‐Hla Thein (14 shared papers)Janaki Amin (69 shared papers)Andrew R. Lloyd (80 shared papers)
- Journals
- Journal of Hepatology (51 papers)Journal of Viral Hepatitis (43 papers)International Journal of Drug Policy (40 papers)Clinical Infectious Diseases (26 papers)Hepatology (25 papers)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Gregory J. Dore
497 papers receiving 23.6k citations
Gregory J. Dore's Hit Papers
Peers
Comparison fields: 5 of 169
- Hepatology 16.2k
- Epidemiology 11.6k
- Virology 1.1k
- Infectious Diseases 2.9k
- Microbiology 382
Countries citing papers authored by Gregory J. Dore
This map shows the geographic impact of Gregory J. Dore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory J. Dore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory J. Dore more than expected).
Fields of papers citing papers by Gregory J. Dore
This network shows the impact of papers produced by Gregory J. Dore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory J. Dore. The network helps show where Gregory J. Dore may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory J. Dore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 514 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy Hit paper breakdown → | 2009 | 1501 |
| 2 | Epidemiology and natural history of HCV infection Hit paper breakdown → | 2013 | 784 |
| 3 | Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies Hit paper breakdown → | 2005 | 680 |
| 4 | Estimation of stage‐specific fibrosis progression rates in chronic hepatitis C virus infection Hit paper breakdown → | 2008 | 659 |
| 5 | Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection Hit paper breakdown → | 2022 | 611 |
| 6 | 2001 | 490 | |
| 7 | Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals Hit paper breakdown → | 2013 | 374 |
| 8 | Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression Hit paper breakdown → | 2017 | 351 |
| 9 | 1999 | 348 | |
| 10 | Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2014 | 343 |
| 11 | Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States Hit paper breakdown → | 2015 | 333 |
| 12 | 2008 | 318 | |
| 13 | 2009 | 252 | |
| 14 | 2013 | 242 | |
| 15 | 2013 | 231 | |
| 16 | 2006 | 217 | |
| 17 | 2004 | 203 | |
| 18 | 2011 | 202 | |
| 19 | 2016 | 201 | |
| 20 | 2003 | 191 |
About Gregory J. Dore
Gregory J. Dore is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Virology and Public Health, Environmental and Occupational Health, having authored 514 papers that have together received 24.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (356 papers), Hepatitis B Virus Studies (158 papers), Liver Disease Diagnosis and Treatment (112 papers), HIV, Drug Use, Sexual Risk (58 papers), HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (17 papers), HIV/AIDS Research and Interventions (12 papers) and Opioid Use Disorder Treatment (11 papers). The work is most often cited by research in Hepatology (16.2k citations), Epidemiology (11.6k citations), Virology (1.1k citations), Infectious Diseases (2.9k citations) and Microbiology (382 citations). Gregory J. Dore has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Jason Grebely, John Kaldor, Behzad Hajarizadeh, Matthew Law, Gail Matthews, Hla‐Hla Thein, Janaki Amin, Andrew R. Lloyd, Murray Krahn and J. Micallef. Their work appears in journals such as Journal of Hepatology, Journal of Viral Hepatitis, International Journal of Drug Policy, Clinical Infectious Diseases and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.